Serial Number
86739853
Owner
CytomX Therapeutics, Inc.Attorney
Janet L. CullumFiling Date
Aug 27, 2015
IHZ Trademark
Serial Number: 86739853
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
151 Oyster Point Blvd, Suite 400
South San Francisco, CA 94080
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
August 27, 2015
Registration Date
Not Registered
Published for Opposition
March 29, 2016
Goods & Services
Assays and reagents for use in medical, diagnostic and therapeutic purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, and antibody binding, for use in identifying candidate patient populations for specific therapeutic treatments
Assays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding, for scientific, laboratory and research purposes; assay kits comprised of assays and for non-medical purposes for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding
Providing scientific research information and analysis relating to biochemicals, proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments